These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 37250173)

  • 1. Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances.
    Zhang E; Phan P; Zhao Z
    Acta Pharm Sin B; 2023 May; 13(5):1789-1827. PubMed ID: 37250173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coincident Fluorescence-Burst Analysis of the Loading Yields of Exosome-Mimetic Nanovesicles with Fluorescently-Labeled Cargo Molecules.
    Sanaee M; Sandberg E; Ronquist KG; Morrell JM; Widengren J; Gallo K
    Small; 2022 Mar; 18(12):e2106241. PubMed ID: 35084110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation.
    Sayyed AA; Gondaliya P; Yan IK; Carrington J; Driscoll J; Moirangthem A; Patel T
    Nanomaterials (Basel); 2023 Oct; 13(20):. PubMed ID: 37887902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-derived exosome-like nanovesicles: A novel nanotool for disease therapy.
    Jin Z; Na J; Lin X; Jiao R; Liu X; Huang Y
    Heliyon; 2024 May; 10(9):e30630. PubMed ID: 38765146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies.
    Prasad R; Conde J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1792. PubMed ID: 35318815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of lipid nanovesicle drug delivery system in cancer immunotherapy.
    Ding Y; Wang L; Li H; Miao F; Zhang Z; Hu C; Yu W; Tang Q; Shao G
    J Nanobiotechnology; 2022 May; 20(1):214. PubMed ID: 35524277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
    Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
    Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles of immune cells; immunomodulatory impacts and therapeutic potentials.
    Mahmoudi F; Hanachi P; Montaseri A
    Clin Immunol; 2023 Mar; 248():109237. PubMed ID: 36669608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Loading of Biological Nanocarrier Vesicles Derived from Red-Blood-Cell Membranes.
    Sanaee M; Ronquist KG; Sandberg E; Morrell JM; Widengren J; Gallo K
    ACS Omega; 2024 May; 9(21):22711-22718. PubMed ID: 38826552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.
    Tagalakis AD; Maeshima R; Yu-Wai-Man C; Meng J; Syed F; Wu LP; Aldossary AM; McCarthy D; Moghimi SM; Hart SL
    Acta Biomater; 2017 Mar; 51():351-362. PubMed ID: 28110069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of cabbage exosome-like nanovesicles and investigation of their biological activities in human cells.
    You JY; Kang SJ; Rhee WJ
    Bioact Mater; 2021 Dec; 6(12):4321-4332. PubMed ID: 33997509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Membrane Components-Mediated Cancer Immunotherapeutic Platforms.
    Yun S; Kim S; Kim K
    Macromol Biosci; 2023 Nov; 23(11):e2300159. PubMed ID: 37319369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicle-Mimetic Ghost Nanovesicles for Delivering Anti-Inflammatory Drugs to Mitigate Gram-Negative Bacterial Outer Membrane Vesicle-Induced Systemic Inflammatory Response Syndrome.
    Go G; Lee J; Choi DS; Kim SS; Gho YS
    Adv Healthc Mater; 2019 Feb; 8(4):e1801082. PubMed ID: 30549424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Technologies for Exosome and Exosome-like Nanovesicle Procurement and Enhancement.
    Martínez-Santillán A; González-Valdez J
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting Sound for Emerging Applications of Extracellular Vesicles.
    Wu Z; Cai H; Tian C; Ao Z; Jiang L; Guo F
    Nano Res; 2024 Feb; 17(2):462-475. PubMed ID: 38712329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy.
    Cheng Q; Kang Y; Yao B; Dong J; Zhu Y; He Y; Ji X
    Adv Sci (Weinh); 2023 Sep; 10(26):e2302131. PubMed ID: 37409429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner.
    Luhtala N; Aslanian A; Yates JR; Hunter T
    J Biol Chem; 2017 Jan; 292(2):611-628. PubMed ID: 27909058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical Immunoengineering of T cells for Therapeutic Applications.
    Lei K; Kurum A; Tang L
    Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review.
    Alhamhoom Y; Kakinani G; Rahamathulla M; Ali M Osmani R; Hani U; Yoonus Thajudeen K; Kiran Raj G; Gowda DV
    Saudi Pharm J; 2023 Feb; 31(2):279-294. PubMed ID: 36942270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.